Skip to main content

Table 3 Multivariate analysis of factors associated with OS and DFS in all surgical patients

From: Clinical efficacy of liver resection after downsizing systemic chemotherapy for initially unresectable liver metastases

OS

HR

95 % CI

p

Age >65 years

5.90

2.57–14.5

<0.001

Male

1.12

0.52–2.62

0.780

Synchronous disease

2.85

1.28–7.03

0.009

DFS

HR

95 % CI

p

Synchronous disease

1.08

0.57–2.05

0.809

Conversion disease

1.32

0.59–2.90

0.491

No. of liver metastases ≥5

1.68

0.85–3.26

0.137

Maximum tumor size >5 cm

1.59

0.80–3.02

0.179

  1. OS overall survival, DFS disease-free survival, HR hazard ratio, CI confidence interval